The 2025 GOLD COPD report has a new emphasis on CV disease and PH in COPD and major updates on new drugs, climate change, and ...

Postpartum diabetes risk was elevated among women with a history of gestational diabetes and a high-stable or inverse U-shaped BMI trajectory.

In 2021, there were an estimated 192,000 global cases of pulmonary arterial hypertension, and 62% of these were in female patients. Pulmonary arterial hypertension (PAH) disproportionately affects ...

Only 4 of 25 synthetic nicotine brand accounts featured health warnings in their social media profiles. Almost 90% of sampled Instagram posts from synthetic nicotine brand accounts did not adhere to ...

Lithium aspartate does not provide significant relief for post-COVID-19 symptoms of fatigue or cognitive dysfunction.

Using single maintenance and reliever therapy (SMART) is cost‐effective vs ICS/LABA maintenance plus SABA reliever in uncontrolled asthma.

Topline results were announced from a phase 3 trial evaluating SC pembrolizumab with berahyaluronidase alfa in metastatic NSCLC.

Metformin use was associated with longer overall survival in a cohort of patients with non-small cell lung cancer and the subgroup of patients with a BMI of 25 or higher but not in patients with a BMI ...

Every 1-unit decrease in serum 25(OH)D levels was associated with a 0.7 obstructive AHI increase. Vitamin D deficiency is commonly observed in pediatric obstructive sleep apnea, and vitamin D levels ...

Machine learning analysis of photo and video data demonstrates a promising way to noninvasively detect early hypertension and diabetes.

In IPF, antifibrotic therapy discontinuation was linked to patient variables that included depression, lower DLCO, and higher all-cause mortality.

Casirivimab and imdevimab in combination is safe among pediatric outpatients with at least 1 risk factor for severe COVID-19.